Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.

Ke M, Zou D, Yuan Y, Li Y, Lin L, Hao J, Hou X, Kim HJ.

Neurogastroenterol Motil. 2013 Jan;25(1):90-1. doi: 10.1111/nmo.12033. No abstract available.

2.

Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.

Morais SA, Ford AC.

Neurogastroenterol Motil. 2013 Jan;25(1):89. doi: 10.1111/nmo.12026. No abstract available.

3.

Prucalopride: a new drug for the treatment of chronic constipation.

Tack J.

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):337-43. doi: 10.1586/egh.09.38. Review.

PMID:
19673621
4.

Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.

Krogh K, Jensen MB, Gandrup P, Laurberg S, Nilsson J, Kerstens R, De Pauw M.

Scand J Gastroenterol. 2002 Apr;37(4):431-6.

PMID:
11989834
5.

Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.

Ke M, Zou D, Yuan Y, Li Y, Lin L, Hao J, Hou X, Kim HJ.

Neurogastroenterol Motil. 2012 Nov;24(11):999-e541. doi: 10.1111/j.1365-2982.2012.01983.x. Epub 2012 Aug 8.

6.

Prucalopride. In chronic constipation: poorly documented risks.

[No authors listed]

Prescrire Int. 2011 May;20(116):117-20.

PMID:
21648173
7.

Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.

Tack J, Corsetti M.

Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1327-35. doi: 10.1517/17425255.2012.719497. Review.

PMID:
22985444
8.

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study.

Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L.

Neurogastroenterol Motil. 2009 Dec;21(12):1256-e117. doi: 10.1111/j.1365-2982.2009.01398.x. Epub 2009 Sep 9.

9.

[Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].

Layer P, Dathe K, Dignass A, Faiss S, Galle P, Lerch MM, Malfertheiner P, Wehrmann T, Zeuzem S.

Z Gastroenterol. 2011 Aug;49(8):969-70. doi: 10.1055/s-0031-1273444. Epub 2011 Jul 27. German. No abstract available.

PMID:
21796580
10.

[New treatment option for women with chronic constipation - prucalopride stimulates the disturbed gut motility again].

[No authors listed]

Z Gastroenterol. 2011 Jan;49(1):e1-2. doi: 10.1055/s-0030-1254864. Epub 2011 Jan 17. German. No abstract available.

PMID:
21243595
11.

[Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].

Osipenko MF, Bikbulatova EA, Skalinskaia MA, Kulygina IuA, Pankova LIu.

Ter Arkh. 2013;85(12):60-4. Russian.

PMID:
24640670
12.

Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.

Pennant M, Orlando R, Barton P, Bayliss S, Routh K, Meads C.

Health Technol Assess. 2011 May;15 Suppl 1:43-50. doi: 10.3310/hta15suppl1/05. Review.

14.

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.

Sloots CE, Poen AC, Kerstens R, Stevens M, De Pauw M, Van Oene JC, Meuwissen SG, Felt-Bersma RJ.

Aliment Pharmacol Ther. 2002 Apr;16(4):759-67.

15.

Motility: prucalopride for chronic constipation.

Bassotti G, Villanacci V.

Nat Rev Gastroenterol Hepatol. 2009 Jun;6(6):324-5. doi: 10.1038/nrgastro.2009.81. No abstract available.

PMID:
19494821
16.

Prucalopride for constipation.

Camilleri M, Deiteren A.

Expert Opin Pharmacother. 2010 Feb;11(3):451-61. doi: 10.1517/14656560903567057. Review.

PMID:
20102308
17.

The use of Resolor (prucalopride) for chronic constipation in women.

Woodward S.

Br J Nurs. 2012 Sep 13-26;21(16):982, 984-6.

PMID:
23123655
18.

A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation.

Müller-Lissner S, Rykx A, Kerstens R, Vandeplassche L.

Neurogastroenterol Motil. 2010 Sep;22(9):991-8, e255. doi: 10.1111/j.1365-2982.2010.01533.x. Epub 2010 Jun 7.

19.

Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.

Dubois D, Gilet H, Viala-Danten M, Tack J.

Neurogastroenterol Motil. 2010 Feb;22(2):e54-63. doi: 10.1111/j.1365-2982.2009.01408.x. Epub 2009 Sep 17.

20.

Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.

Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L.

Aliment Pharmacol Ther. 2010 Nov;32(9):1113-23. doi: 10.1111/j.1365-2036.2010.04455.x. Epub 2010 Sep 16.

Items per page

Supplemental Content

Write to the Help Desk